Dollard des Ormeaux, Canada

Leslie G Humber


Average Co-Inventor Count = 2.8

ph-index = 12

Forward Citations = 553(Granted Patents)


Inventors with similar research interests:


Location History:

  • Montreal, CA (1977)
  • Dollard des Ormeaux, CA (1976 - 1986)
  • North Brunswick, NJ (US) (1985 - 1990)
  • No. Brunswick, NJ (US) (1991)
  • Brunswick, NJ (US) (1998 - 1999)

Company Filing History:


Years Active: 1976-1999

Loading Chart...
Areas of Expertise:
Oral Formulations
Benzopyran Derivatives
Antihypertensive Compounds
Tetrahydropyrano Indole
Cyclohexaneacetic Acid
Carbazole Derivatives
Aminoethanol Derivatives
Isoindole Derivatives
Neuroleptics
Spiroindolones
Polycyclic Heterocycles
Furoquinolines
83 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Leslie G. Humber

Introduction

Leslie G. Humber, based in Dollard des Ormeaux, Canada, is a prolific inventor recognized for his extensive contributions to pharmaceutical formulations. With an impressive portfolio of 83 patents, Humber's work has significantly impacted the field of medicinal chemistry and drug delivery systems.

Latest Patents

Among his latest innovations are two notable patents focusing on oral formulations. The first, titled "Oral Formulations of S(+)-etodolac," details organoleptically acceptable formulations that incorporate non-solubilized S(+) 1,8-diethyl-1,3,4,9-tetrahydropyrano-3,4-b!indole-1-acetic acid, which is often referred to as S(+)etodolic acid or S(+)etodolac. The second patent, "Oral Formulations of S(+)-ibuprofen," presents formulations containing S(+)-2-(p-isobutylphenyl)-propionic acid, widely known as S(+) ibuprofen. Both innovations underpin Humber's commitment to enhancing drug formulation efficacy and patient compliance.

Career Highlights

Leslie G. Humber has had a distinguished career, including significant tenures at reputable companies such as American Home Products Corporation and Ayerst, McKenna & Harrison, Inc. His expert insights and dedication to research have fostered advancements in pharmaceutical products that benefit both healthcare professionals and patients.

Collaborations

Throughout his career, Humber has worked alongside talented colleagues, including Christopher A. Demerson and Andre A. Asselin. These collaborations have contributed to a collaborative atmosphere that promotes innovation and research excellence in their field.

Conclusion

In summary, Leslie G. Humber has made remarkable strides in the pharmaceutical industry through his extensive patent portfolio and collaborative efforts. His latest innovations in oral formulations of S(+)-etodolac and S(+)-ibuprofen exemplify his dedication to improving medicinal products and patient outcomes. As a leading inventor, Humber continues to shape the future of drug formulation and delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…